Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Fletcher

Showing results (51-60 of 205) with videos related to

Pageof 21
Sort By:
The American Journal of Surgical Pathology|August 13, 2005
Cytogenetic aberrations in perineurioma: variation with subtypeJane E Brock, Antonio R Perez-Atayde, Harry P W Kozakewich, et al.
Cancer Cytopathology|May 15, 2018
Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsyInga-Marie Schaefer, Jonathan A Fletcher, G Petur Nielsen, et al.
Pediatric Blood & Cancer|October 27, 2004
Imatinib mesylate: an attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuberansVictoria E Price, Jonathan A Fletcher, Maria Zielenska, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|September 2, 2006
Cytogenetic and p53 profiles in congenital cystic adenomatoid malformation: insights into its relationship with pleuropulmonary blastomaSara O Vargas, Esther Korpershoek, Harry P W Kozakewich, et al.
Cancer Research|March 17, 2007
Histone H2AX is a mediator of gastrointestinal stromal tumor cell apoptosis following treatment with imatinib mesylateYing Liu, Michelle Tseng, Sophie A Perdreau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumorsSamuel Singer, Brian P Rubin, Marcia L Lux, et al.
British Journal of Haematology|April 3, 2003
Detection by the fluorescence in situ hybridization technique of MYC translocations in paraffin-embedded lymphoma biopsy samplesEugenia Haralambieva, Alison H Banham, Christian Bastard, et al.
Journal of Medicinal Chemistry|May 28, 2009
Targeting human gastrointestinal stromal tumor cells with a quadruplex-binding small moleculeMekala Gunaratnam, Stephen Swank, Shozeb M Haider, et al.
The American Journal of Surgical Pathology|February 28, 2008
Osteofibrous dysplasia and adamantinoma in children and adolescents: a clinicopathologic reappraisalBriana C Gleason, Bernadette Liegl-Atzwanger, Harry P Kozakewich, et al.
Oncogenesis|May 5, 2021
YWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathwaysWen-Bin Ou, Meijun Z Lundberg, Shuihao Zhu, et al.
Pageof 21

Showing results (51-60 of 205) with videos related to

Sort By:
Pageof 21
The American Journal of Surgical Pathology|August 13, 2005
Cytogenetic aberrations in perineurioma: variation with subtypeJane E Brock, Antonio R Perez-Atayde, Harry P W Kozakewich, et al.
Cancer Cytopathology|May 15, 2018
Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsyInga-Marie Schaefer, Jonathan A Fletcher, G Petur Nielsen, et al.
Pediatric Blood & Cancer|October 27, 2004
Imatinib mesylate: an attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuberansVictoria E Price, Jonathan A Fletcher, Maria Zielenska, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|September 2, 2006
Cytogenetic and p53 profiles in congenital cystic adenomatoid malformation: insights into its relationship with pleuropulmonary blastomaSara O Vargas, Esther Korpershoek, Harry P W Kozakewich, et al.
Cancer Research|March 17, 2007
Histone H2AX is a mediator of gastrointestinal stromal tumor cell apoptosis following treatment with imatinib mesylateYing Liu, Michelle Tseng, Sophie A Perdreau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumorsSamuel Singer, Brian P Rubin, Marcia L Lux, et al.
British Journal of Haematology|April 3, 2003
Detection by the fluorescence in situ hybridization technique of MYC translocations in paraffin-embedded lymphoma biopsy samplesEugenia Haralambieva, Alison H Banham, Christian Bastard, et al.
Journal of Medicinal Chemistry|May 28, 2009
Targeting human gastrointestinal stromal tumor cells with a quadruplex-binding small moleculeMekala Gunaratnam, Stephen Swank, Shozeb M Haider, et al.
The American Journal of Surgical Pathology|February 28, 2008
Osteofibrous dysplasia and adamantinoma in children and adolescents: a clinicopathologic reappraisalBriana C Gleason, Bernadette Liegl-Atzwanger, Harry P Kozakewich, et al.
Oncogenesis|May 5, 2021
YWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathwaysWen-Bin Ou, Meijun Z Lundberg, Shuihao Zhu, et al.
Pageof 21